HAE

Haemonetics Corp

119.65

Oct 30 • 3:59 PM ET -0.14 (-0.12%)

119.65

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Medical Devices USA Mid NYSE

Peers: TFX MMSI CERS ABT PEN BDX ICUI BAX BSX GRFS

| Held by: IJH VTI IWM VB VXF IWO DFAS MDY VBR VBK

Scroll to Statements

Index	RUT
Market Cap	5.44B
Enterprise Value	6.39B
Income	96.29M
Sales	1.35B
Book/sh	18.41
Cash/sh	4.91
Dividend Est.	1.00 (0.84%)
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	3009
IPO	May 10, 1991

P/E	58.36
Forward P/E	20.57
PEG	2.01
P/S	4.03
P/B	6.50
P/C	24.37
P/FCF	18.69
EV/EBITDA	17.84
EV/Sales	4.73
Quick Ratio	1.91
Current Ratio	3.08
Debt/Eq	1.40
LT Debt/Eq	1.40
Option/Short	Yes / Yes

EPS (ttm)	2.05
EPS next Y	5.82
EPS next Q	1.29
EPS this Y	7.12%
EPS next Y	9.50%
EPS next 5Y	10.25%
EPS past 3/5Y	-2.90% 5.81%
Sales past 3/5Y	4.51% 8.91%
EPS Y/Y TTM	-37.48%
Sales Y/Y TTM	0.44%
EPS Q/Q	2.63%
Sales Q/Q	5.60%
Earnings	Nov 05 BMO
EPS/Sales Surpr.	5.87% 3.51%

Insider Own	1.88%
Insider Trans	0.00%
Inst Own	109.72%
Inst Trans	3.41%
ROA	3.99%
ROE	11.20%
ROIC	4.80%
Gross Margin	55.91%
Oper. Margin	18.37%
Profit Margin	7.12%
SMA20	2.34%
SMA50	8.80%
SMA200	52.16%
Trades

Shs Outstand	45.47M
Shs Float	44.64M
Short Float	7.68%
Short Ratio	4.71
Short Interest	3.43M
52W High	123.77 -3.33%
52W Low	49.00 144.18%
Volatility	2.36% 2.92%
ATR (14)	3.28
RSI (14)	63.27
Beta	0.65
Rel Volume	0.62
Avg Volume	728.23K
Volume	453,400

Perf Week	0.96%
Perf Month	14.64%
Perf Quarter	37.86%
Perf Half Y	101.91%
Perf YTD	49.28%
Perf Year	139.35%
Perf 3Y	40.90%
Perf 5Y	74.14%
Perf 10Y	261.04%
Recom	1.67
Target Price	124.50
Prev Close	119.79
Price	119.65
Change %	-0.12%

Consensus

Buy

Avg. Price Target

$124.50

Implied Upside

+4.1%

Analysts10incl. previous ratings

Rating Distribution8 Buy · 2 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 17, 2026	Upgrade	CCitigroup	Neutral → Buy	$123	+2.8%
May 22, 2026	Upgrade	BBofA Securities	Neutral → Buy	$80	-33.1%
May 12, 2026	Reiterated	BBarrington Research	Outperform	$94 → $89	-25.6%
Dec 15, 2025	Downgrade	NNeedham	Buy → Hold
Dec 11, 2025	Downgrade	CCitigroup	Buy → Neutral	$88	-26.5%
Aug 11, 2025	Downgrade	RRaymond James	Strong Buy → Outperform	$78	-34.8%
Aug 08, 2025	Reiterated	BBarrington Research	Outperform	$95 → $86	-28.1%
Aug 08, 2025	Downgrade	JJP Morgan	Overweight → Neutral	$62	-48.2%
Jul 09, 2025	Upgrade	CCitigroup	Neutral → Buy	$90	-24.8%
Jun 26, 2025	Initiated	RRobert W. Baird	Outperform	$87	-27.3%
Feb 07, 2025	Downgrade	BBofA Securities	Neutral → Underperform	$95 → $68	-43.2%
Dec 06, 2024	Initiated	JJP Morgan	Overweight	$116	-3.1%
Nov 08, 2024	Upgrade	RRaymond James	Outperform → Strong Buy	$120	+0.3%
Sep 13, 2024	Initiated	CCL King	Buy	$116	-3.1%
Sep 11, 2024	Initiated	BBofA Securities	Neutral	$85	-29.0%
Sep 10, 2024	Initiated	BBTIG Research	Buy	$112	-6.4%
Jun 12, 2024	Upgrade	NNeedham	Hold → Buy	$112	-6.4%
Oct 13, 2022	Initiated	MMizuho	Buy	$90	-24.8%
Jan 27, 2022	Downgrade	NNeedham	Buy → Hold
Dec 15, 2021	Downgrade	CCitigroup	Buy → Neutral	$75 → $59	-50.7%

Oct-28-26 02:25PM	Haemonetics Must Prove Its Vascular Turnaround Is Durable After A 40% Rally (Earnings Whispers)
Oct-19-26 06:11PM	Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50-Day Line (PR Newswire)
04:15PM	Haemonetics Announces FDA Approval of PerQseal Elite Vascular Closure System (PR Newswire)
Oct-08-26 01:48PM	HAE, PCRX Stocks Hit Multi-Year Highs Amid Broader Market Selloff Whats Driving The Momentum Today? (Stocktwits) +17.46%
11:18AM	Haemonetics shares jump as CSL sets 2027 rollout of plasma devices (Proactive)
10:30AM	Loading…
10:30AM	Haemonetics Soars 12% on CSL Update: Plasma Giant to Roll Out NexSys Across U.S. Centers (TIKR)
10:09AM	Haemonetics Stock Surges as Plasma Deal Opens Door to More Revenue (Barrons.com)
09:13AM	Haemonetics stock surges 17% on CSL Plasma supply deal update (Investing.com)
Sep-30-26 04:05PM	Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026 (PR Newswire)
Sep-17-26 01:56PM	HAE, TWST Stocks Jump To Over 5-Year Highs Whats Driving The Gains Today? (Stocktwits)
09:47AM	Lyft downgraded, Trip.com upgraded: Wall Street's top analyst calls (The Fly)
Aug-14-26 02:00PM	John Rogers's Top Q2 2026 Move: Haemonetics Corp at a 1.54% Portfolio Impact (GuruFocus.com)
Aug-11-26 08:00AM	David Nierenberg's Top Q2 2026 Move: FTI Consulting Inc at a 4.75% Portfolio Impact (GuruFocus.com)
Aug-06-26 03:06PM	Haemonetics Corp (HAE) (Q1 2027) Earnings Call Highlights: Strong Start Drives Raised Guidance (GuruFocus.com)
06:08AM	Haemonetics: Fiscal Q1 Earnings Snapshot (Associated Press)
06:00AM	Loading…
06:00AM	Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website (PR Newswire)
Aug-03-26 04:15PM	New Study Offers Additional Evidence for the VASCADE MVP XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths (PR Newswire)
Jul-28-26 04:15PM	Martin Madaus Elected to Haemonetics Board of Directors (PR Newswire)
Jul-08-26 04:05PM	Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026 (PR Newswire)
Jun-05-26 06:30AM	Haemonetics Updates Financial Reporting Segments (PR Newswire)
Jun-02-26 04:05PM	Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference (PR Newswire)
May-07-26 06:09AM	Haemonetics: Fiscal Q4 Earnings Snapshot (Associated Press)
06:00AM	Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website (PR Newswire)
May-05-26 06:00AM	Haemonetics to Present at Bank of America 2026 Healthcare Conference (PR Newswire)
Apr-24-26 06:20AM	New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP XL in Large-Bore Venous Access Closure Procedures (PR Newswire)
Apr-01-26 04:05PM	Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026 (PR Newswire)
Mar-30-26 09:01PM	GVS SpA (STU:4YQ) Q4 2025 Earnings Call Highlights: Strong Safety Division Growth Amidst Challenges (GuruFocus.com)
04:15PM	Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP XL Venous Vascular Closure System (PR Newswire)
Mar-11-26 05:26AM	Haemonetics price target lowered to $70 from $75 at Citi (TipRanks)
Mar-05-26 10:35PM	A Look Back at Medical Devices & Supplies - Specialty Stocks' Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack (StockStory)
11:04PM	Loading…
Mar-03-26 11:04PM	3 Reasons HAE is Risky and 1 Stock to Buy Instead (StockStory)
Mar-02-26 09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
Feb-23-26 04:15PM	Haemonetics Receives FDA Clearance for NexSys PCS Plasma Collection System with Persona PLUS Technology (PR Newswire)
Feb-20-26 04:05PM	Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference (PR Newswire)
Feb-18-26 01:13AM	Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81 (Insider Monkey)
Feb-16-26 09:16AM	Strong Competitive Position Drove Haemonetics Corporation's (HAE) Earnings Growth (Insider Monkey)
Feb-12-26 12:34AM	5 Revealing Analyst Questions From Haemonetics's Q4 Earnings Call (StockStory)
Feb-10-26 09:15AM	Haemonetics (HAE) International Revenue Performance Explored (Zacks)
Feb-09-26 05:03PM	Chuck Royce's Strategic Moves: Significant Reduction in Haemonetics Corp (GuruFocus.com)
09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Feb-06-26 06:28PM	Haemonetics Q3 Earnings Call Highlights (MarketBeat) -8.74%
09:45AM	Haemonetics (HAE) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
09:31AM	Haemonetics Q3 Earnings & Revenues Beat, Margins Up, Stock Slips (Zacks)
12:34AM	HAE Q4 Deep Dive: Plasma Momentum and Hospital Weakness Shape Mixed Results (StockStory)
Feb-05-26 02:04PM	Haemonetics Corp (HAE) Q3 2026 Earnings Call Highlights: Strong Plasma Growth and Margin ... (GuruFocus.com)
09:30AM	Haemonetics (HAE) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
07:20AM	Haemonetics (HAE) Q3 Earnings and Revenues Beat Estimates (Zacks)
06:35AM	Haemonetics's (NYSE:HAE) Q4 CY2025 Sales Top Estimates, Stock Soars (StockStory)
06:23AM	Haemonetics: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website (PR Newswire)
Feb-03-26 10:03PM	What To Expect From Haemonetics's (HAE) Q4 Earnings (StockStory)
Jan-30-26 02:31PM	Haemonetics (HAE) Sparks Confidence Following Vivasure Acquisition (Insider Monkey)
Jan-29-26 05:25PM	Stryker (SYK) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
Jan-28-26 10:33PM	Reflecting On Medical Devices & Supplies - Specialty Stocks' Q3 Earnings: Haemonetics (NYSE:HAE) (StockStory)
Jan-22-26 09:40AM	Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Jan-15-26 09:42AM	Is it Apt to Retain HAE Stock in Your Portfolio for Now? (Zacks)
Jan-13-26 07:44AM	Haemonetics price target raised to $93 from $90 at Barrington (TipRanks)
Jan-12-26 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)
06:53AM	Haemonetics acquires Ireland-based Vivasure (Medical Device Network)
Jan-09-26 12:10PM	Will Haemonetics (HAE) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:41AM	Haemonetics to acquire Vivasure Medical (MedTech Dive)
08:16AM	Haemonetics Expands Heart Surgery Arsenal With Vivasure Acquisition (Benzinga)
08:00AM	Vivasure Medical Announces Acquisition by Haemonetics Corporation (Business Wire)
06:15AM	Haemonetics Acquires Vivasure Medical Limited (PR Newswire)
Jan-08-26 11:33PM	1 Small-Cap Stock Worth Your Attention and 2 We Avoid (StockStory)
Jan-07-26 06:17PM	Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026 (PR Newswire)
Jan-06-26 09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Jan-02-26 06:00AM	Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-25-25 07:42AM	Do You Believe in the Long-Term Growth Potential of Haemonetics Corporation (HAE)? (Insider Monkey)
Dec-19-25 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)
Dec-18-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-16-25 12:26PM	Health Care Roundup: Market Talk (The Wall Street Journal)
08:15AM	Riverwater Partners Small Cap Strategy Sold Its Stake in Haemonetics Corporation (HAE) in Q3 (Insider Monkey)
Dec-15-25 12:46PM	Why Haemonetics (HAE) Shares Are Trading Lower Today (StockStory)
09:50AM	Here's Why Haemonetics (HAE) is a Strong Momentum Stock (Zacks)
Dec-12-25 07:11AM	Is it Apt to Retain Haemonetics Stock in Your Portfolio Now? (Zacks)
Dec-11-25 11:41AM	Why Haemonetics (HAE) Stock Is Down Today (StockStory)
Dec-03-25 09:45AM	Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term (Zacks)
Nov-28-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Nov-17-25 11:02PM	3 Reasons to Sell HAE and 1 Stock to Buy Instead (StockStory)
09:15AM	Interpreting Haemonetics (HAE) International Revenue Trends (Zacks)
Nov-14-25 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)
Nov-13-25 09:50AM	Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term (Zacks)
12:37AM	5 Insightful Analyst Questions From Haemonetics's Q3 Earnings Call (StockStory)
Nov-11-25 09:40AM	Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Nov-07-25 12:47PM	Why Haemonetics Stock Was on Fire Thursday (Motley Fool)
09:45AM	HAE Q3 Deep Dive: Margin Expansion and Portfolio Rationalization Drive Outperformance (StockStory)
Nov-06-25 02:04PM	Haemonetics Corp (HAE) Q2 2026 Earnings Call Highlights: Strong Plasma Growth and Margin ... (GuruFocus.com) +32.31%
01:56PM	Why Are Haemonetics (HAE) Shares Soaring Today (StockStory)
11:09AM	Stock Market Today: U.S. Stocks Plummet After Fed Comments, Surprise Layoff Data, and Threat of U.S. Flight Cuts (TheStreet)
09:30AM	Haemonetics (HAE) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
08:57AM	Haemonetics (NYSE:HAE) Delivers Impressive Q3, Stock Jumps 12.8% (StockStory)
07:15AM	Haemonetics (HAE) Q2 Earnings and Revenues Surpass Estimates (Zacks)
06:12AM	Haemonetics: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website (PR Newswire)
Nov-04-25 10:08PM	What To Expect From Haemonetics's (HAE) Q3 Earnings (StockStory)
08:05AM	Haemonetics Corporation (HAE) is Navigating Challenges Through Earnings Growth (Insider Monkey)
Nov-03-25 08:11AM	Should You Hold Haemonetics Corporation (HAE)? (Insider Monkey)
Oct-28-25 12:01AM	Haemonetics (HAE): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KROLL MARK W	Director	Nov 10 '25	Buy	70.56	1,400	98,784	24,757	Nov 12 04:18 PM

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

CEOMr. Christopher A. Simon

CFOMr. James C. D'Arecca CPA

Executive VP & COOMr. Frank W. Chan Ph.D.

J.D.Ms. Michelle L. Basil Esq.

Executive VP & Chief Commercial OfficerMr. Roy Galvin

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HAE

Haemonetics Corp

Upgrade your Finviz experience